{"id":"W2899751126","doi":"10.1016/j.jhep.2018.10.035","title":"Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trial","year":2018,"lang":"en","type":"article","venue":"Journal of Hepatology","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":180,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; University Health Network","funders":"Birmingham Biomedical Research Centre; National Institute for Health and Care Research; NGM Biopharmaceuticals","keywords":"Primary sclerosing cholangitis; Placebo; FGF19; Medicine; Double blind; Internal medicine; Primary (astronomy); Gastroenterology; Randomized controlled trial; Multicenter trial; Multicenter study; Pathology; Physics; Alternative medicine; Disease; Fibroblast growth factor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003273109,0.00021283,0.002402844,0.0005281654,0.00008929239,0.00001650267,0.000195378,0.0001735759,0.0001449743],"category_scores_gemma":[0.0007431622,0.0001431324,0.0006225263,0.0001874576,0.0003234718,0.0002805675,0.00006559864,0.0004530517,0.00000464471],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001153695,"about_ca_system_score_gemma":0.000299787,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000193328,"about_ca_topic_score_gemma":0.00002522839,"domain_scores_codex":[0.996397,0.001494151,0.001324479,0.000168513,0.0002969906,0.0003188314],"domain_scores_gemma":[0.9974502,0.0007695932,0.0009719233,0.0002734312,0.0003156418,0.0002191791],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.979844,0.002896807,0.009270334,0.0001074327,0.0006247373,0.0001531353,0.0003666716,0.000001367739,0.004083274,0.000007081777,0.0001098867,0.002535229],"study_design_scores_gemma":[0.9689308,0.02450642,0.0006490325,0.0002967416,0.0014333,0.0002816246,0.00004284185,0.0008092464,0.002889128,0.00001108695,0.00004368575,0.000106031],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9952323,0.00119988,0.00007328606,0.0001712959,0.0008337438,0.002083177,0.000006674864,0.00001044963,0.0003892312],"genre_scores_gemma":[0.998768,0.0001627706,0.0002100489,0.0002182289,0.0005473456,0.00003050005,0.00002007512,0.00001932518,0.00002375491],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02160961,"threshold_uncertainty_score":0.5836768,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02875585533740809,"score_gpt":0.3502835658058485,"score_spread":0.3215277104684404,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}